ADAP

0.305

22.00% 0.055

시간 외 거래: .29 -0.015 -4.92%

Adaptimmune Therapeutics Plc Adr (ADAP)

개요 뉴스 가격 이력 옵션 체인 Financials 토론 예측

전일 마감가:

$0.25

열려 있는:

$0.253

하루 거래량:

6.75M

Relative Volume:

3.78

시가총액:

$78.46M

수익:

$175.04M

순이익/손실:

$-44.52M

주가수익비율:

-1.6944

EPS:

-0.18

순현금흐름:

$-56.05M

1주 성능:

+32.58%

1개월 성능:

-43.52%

6개월 성능:

-65.13%

1년 성능:

-78.21%

1일 변동 폭

$0.2449

$0.3224

1주일 범위

$0.1951

$0.3224

52주 변동 폭

$0.1951

$1.48

Adaptimmune Therapeutics Plc Adr Stock (ADAP) Company Profile

명칭

Adaptimmune Therapeutics Plc Adr

부문

Healthcare (1161)

산업

Biotechnology (676)

전화

44 1235 430000

주소

60 JUBILEE AVENUE, ABINGDON, OXFORDSHIRE

직원

506

트위터

@Adaptimmune

다음 수익 날짜

2025-03-21

최신 SEC 제출 서류

ADAP's Discussions on Twitter

ADAP을(를) 다른 주식과 비교

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
ADAP Adaptimmune Therapeutics Plc Adr	0.305	78.46M	175.04M	-44.52M	-56.05M	-0.18
VRTX Vertex Pharmaceuticals Inc	483.49	124.48B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	625.60	67.45B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	583.62	35.60B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	266.83	34.53B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	274.78	29.15B	3.81B	-644.79M	-669.77M	-6.24

Adaptimmune Therapeutics Plc Adr Stock (ADAP) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2024-07-30	개시	H.C. Wainwright	Buy
2024-05-30	개시	Scotiabank	Sector Outperform
2023-03-24	개시	Bryan Garnier	Buy
2023-01-03	업그레이드	Guggenheim	Neutral → Buy
2022-11-09	업그레이드	Mizuho	Neutral → Buy
2021-05-28	개시	Barclays	Underweight
2020-04-22	개시	Mizuho	Neutral
2019-08-02	다운그레이드	Guggenheim	Buy → Neutral
2019-05-31	개시	ROTH Capital	Buy
2019-05-30	재개	Citigroup	Buy
2019-05-07	다운그레이드	SVB Leerink	Outperform → Mkt Perform
2017-03-17	개시	Wells Fargo	Market Perform
2016-10-24	다운그레이드	BofA/Merrill	Neutral → Underperform
2016-09-30	개시	Raymond James	Outperform
2016-02-25	개시	Citigroup	Buy
2015-06-01	개시	BofA/Merrill	Neutral
2015-06-01	개시	Guggenheim	Buy
2015-06-01	개시	Leerink Partners	Outperform

모두보기

Adaptimmune Therapeutics Plc Adr 주식(ADAP)의 최신 뉴스

11:02 AM

Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) Today’s Hot Stock - stocksregister.com

11:02 AM

Apr 01, 2025

H.C. Wainwright cuts Adaptimmune stock target to $3, maintains Buy By Investing.com - Investing.com South Africa

Apr 01, 2025

H.C. Wainwright cuts Adaptimmune stock target to $3, maintains Buy - Investing.com India

Apr 01, 2025

Mar 26, 2025

Guggenheim cuts Adaptimmune target to $1.75, maintains Buy By Investing.com - Investing.com South Africa

Mar 26, 2025

Guggenheim cuts Adaptimmune target to $1.75, maintains Buy - Investing.com India

Mar 26, 2025

Mar 24, 2025

Adaptimmune Therapeutics Amends Loan Agreement - Investing.com India

Mar 24, 2025

Mar 21, 2025

Scotiabank cuts Adaptimmune price target to $1.40, keeps rating By Investing.com - Investing.com South Africa

Mar 21, 2025

Scotiabank cuts Adaptimmune price target to $1.40, keeps rating - Investing.com

Mar 21, 2025

Mar 20, 2025

Mizuho maintains Outperform on Adaptimmune, price target $1.50 By Investing.com - Investing.com South Africa

Mar 20, 2025

Mizuho maintains Outperform on Adaptimmune, price target $1.50 - Investing.com

Mar 20, 2025

Earnings call transcript: Adaptimmune Q4 2024 targets $25M sales in 2025 - Investing.com

Mar 20, 2025

Mar 06, 2025

Adaptimmune Therapeutics PLC Sponsored ADR to Host Earnings Call - ACCESS Newswire

Mar 06, 2025

Feb 25, 2025

LAG-3 Immunotherapies Market Set for Rapid Growth in the Coming 10 Years Across the 7MM as Next-Generation Therapies Advance | DelveInsight - GlobeNewswire Inc.

Feb 25, 2025

Analysts Recommend Holding Your Position In Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) - Stocks Register

Feb 25, 2025

Feb 19, 2025

Investing in Adaptimmune Therapeutics Plc ADR (ADAP) Is Getting More Attractive - Knox Daily

Feb 19, 2025

Feb 12, 2025

Potential Price Increase for Coterra Energy Inc (CTRA) After Recent Insider Activity - Knox Daily

Feb 12, 2025

Taking a Closer Look At Dollar Tree Inc (DLTR) Following Its Recent Trade - Knox Daily

Feb 12, 2025

A Guide To The Risks Of Investing In Agilon Health Inc (AGL) - Knox Daily

Feb 12, 2025

Feb 11, 2025

Daily Progress: Quanterix Corp (QTRX) Drop -3.57, Closing at 7.83 - The Dwinnex

Feb 11, 2025

Feb 08, 2025

Following A 4.11% Weekly Incline, Is It Still A Buy For Amylyx Pharmaceuticals Inc (NASDAQ: AMLX)? - Marketing Sentinel

Feb 08, 2025

Should Outset Medical Inc (NASDAQ: OM) Rally After -544.44% Drop From High? - Marketing Sentinel

Feb 08, 2025

Adaptimmune Therapeutics Plc ADR (NASDAQ: ADAP) Stock Falling -5.24% Over A Month – Any Room For Its Value To Rise? – Marketing Sentinel - Marketing Sentinel

Feb 08, 2025

BioVie Inc (NASDAQ: BIVI): How Can A Stock Be Down -4.00% Year To Date, But Still Loser - Marketing Sentinel

Feb 08, 2025

Feb 07, 2025